Commit To Purchase Pacira Pharmaceuticals At $60, Earn 17.9% Annualized Using Options
July 07, 2015 at 11:34 AM EDT
Investors considering a purchase of Pacira Pharmaceuticals Inc. (PCRX) stock, but cautious about paying the going market price of $67.95/share, might benefit from considering selling puts among the alternative strategies at their disposal..